Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics
about
Antibiotics that target protein synthesisTargeting Antibiotic ResistanceAntibiotics in the clinical pipeline at the end of 2015.Antibiotics: where to throw the spanner in the ribosomal machinery?The evolving role of chemical synthesis in antibacterial drug discovery.Advances in MRSA drug discovery: where are we and where do we need to be?Antibacterial oxazolidinones: emerging structure-toxicity relationships.Strategies for the design of RNA-binding small molecules.Antibiotics in development targeting protein synthesis.Prospects for new antibiotics: a molecule-centered perspective.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants.Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.Structural signatures of antibiotic binding sites on the ribosome.Comprehensive spectral identification of key intermediates to the final product of the chiral pool synthesis of radezolidCopper Catalyzed Assembly ofN-Aryloxazolidinones: Synthesis of Linezolid, Tedizolid, and Rivaroxaban
P2860
Q27025271-D27C686F-5819-45FE-BFB8-5F89C5DEBBE4Q28078130-F474668F-EA6E-4006-9A1D-152D058E67BCQ30249262-07866CE5-72C6-45A8-80AE-4682465442B3Q30460344-AC8CE794-7F08-482F-B8DE-69A6CFAA4B7CQ34427652-E17593B3-D111-4A87-BD63-618F8C3CB87FQ37112508-B9AAB195-162B-43AF-8EC0-5BFE82C2B459Q37747401-90A060E1-F2EF-42CA-9A9C-975102018009Q37855857-D7E62E62-DBFA-4B5B-940A-0D25DCB1A215Q37970724-EF2C7F3A-AA22-4396-848F-C2767E1124FCQ38113689-1579CCCC-D897-48D5-926D-77F16C776626Q38958278-E12679FE-8EE8-4534-94B8-920A5ED44E85Q39715575-59005E87-43C9-4E93-B756-196EC645A287Q41789967-105F7FEA-5895-49C9-8424-23BB7CEE7FD0Q41862729-A1DE0A93-CAE4-4A28-AEE8-02BB7701DE46Q41897563-83A27BAF-3E9F-4FB6-9EB2-7C2EEA23D1B4Q42856081-D9E18EE5-D905-4DAE-A39A-743347B2ED8FQ57310724-DC8DDF2D-4E23-4289-AFBD-97413ABBE5E5
P2860
Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Design at the atomic level: de ...... tent orally active antibiotics
@ast
Design at the atomic level: de ...... tent orally active antibiotics
@en
Design at the atomic level: de ...... tent orally active antibiotics
@nl
type
label
Design at the atomic level: de ...... tent orally active antibiotics
@ast
Design at the atomic level: de ...... tent orally active antibiotics
@en
Design at the atomic level: de ...... tent orally active antibiotics
@nl
prefLabel
Design at the atomic level: de ...... tent orally active antibiotics
@ast
Design at the atomic level: de ...... tent orally active antibiotics
@en
Design at the atomic level: de ...... tent orally active antibiotics
@nl
P2093
P3181
P1476
Design at the atomic level: de ...... tent orally active antibiotics
@en
P2093
Alia Orbin
Ashoke Bhattacharjee
Ayomi Oyelere
Dane Springer
Deping Wang
Erin Duffy
Graham Johnson
Jay Farmer
Jennifer Tran
Jiacheng Zhou
P304
P3181
P356
10.1016/J.BMCL.2008.10.011
P407
P577
2008-12-01T00:00:00Z